Mode
Text Size
Log in / Sign up
N/A N=16 Treatment

Support Via Technology: Living and Learning With Advancing FTD

Caregivers Burnout · Frontotemporal Dementia

Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Revised Memory and Behavior Problems Checklist (RMBPC) — 28.5; 25.2; 16.6; 15.8 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
STELLA-FTD (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Oregon Health and Science University
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Revised Memory and Behavior Problems Checklist (RMBPC)
28.5; 25.2; 16.6; 15.8
SECONDARY
Quality of Life Alzheimer's Disease, Care Partner
37.6; 36.2
SECONDARY
Family Caregiver Self-Efficacy Scale
61.1; 62.8
SECONDARY
Center for Epidemiologic Studies Depression
10.8; 11.3
SECONDARY
Marwit Meuser Caregiver Grief Index
54.2; 55.3
SECONDARY
Caregiver Guilt Questionnaire (CGQ)
2.23; 1.92; 2.31; 2.46; 4.38; 4.77
SECONDARY
Experience Survey
13; 13; 12; 13; 13; 13
SECONDARY
Ten-Item Personality Inventory (TIPI)
51
SECONDARY
Sleep Hygiene Index
10.2
SECONDARY
Contact Survey
11; 2

Summary

Much effort over the last several decades has been devoted to developing and implementing psychoeducational interventions for family caregiving partners for those with Alzheimer's and relatedm dementias (ADRD). However, few interventions address the specific needs of care partners for those with frontotemporal degeneration (FTD). This study tests an intervention to support family caregivers for those with FTD.

Eligibility Criteria

Inclusion Criteria

  • Care Partner for family member, close friend or kin with FTD, primary progressive aphasia, progressive supranuclear palsy or other frontotemporal degenerative dementia
  • Must speak English
  • Must be able to see and hear the videoconference-based interactions.

Exclusion Criteria

  • Family member does not care for someone with FTD conditions.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05338710). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search